Insights

Why BioNTech Stock Crushed the Market Today

What happened
Shares of top coronavirus stock BioNTech (NASDAQ: BNTX) nicely bucked the general downward trend of the market on Monday. The Germany-based biotech’s stock closed more than 5% higher on the day, against the 0.6% rise of the S&P 500 index.
A continued rise in coronavirus cases kept investors interested, but a stronger catalyst was the launch of a stock repurchase program.
So what
That program was announced at the end of March; specifically, BioNTech will buy back up to $1.5 billion worth of its U.S.-listed shares over the next two years. Monday was the start of the initiative.
Image source: Getty Images.

In the original press release heralding the move, BioNTech said it would use the repurchased shares to take care of share-based payment obligations it has committed to.
The biotech quoted its chief financial officer, Jens Holstein, as saying: “We would like our shareholders to participate in our strong 2021 performance through a repurchase program of BioNTech shares. This is in line with our capital allocation strategy and our aim to continue to drive shareholder value.”
As is typical with share buybacks, BioNTech’s current initiative will see the company make its purchases from time to time, and in accordance with market conditions. 
Now what
Meanwhile, the number of coronavirus cases is on the rise in many American cities, not to mention other municipalities and regions around the globe. While this doesn’t necessarily mean that we’re entering a new and frightening phase (the total number of cases is still low relative to the worst months of the pandemic, and fatalities are declining), it is a source of concern.
Should the situation worsen, Comirnaty, the vaccine developed by BioNTech in partnership with Pfizer, will again be a go-to solution for keeping the coronavirus at bay.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. –

What happened

Shares of top coronavirus stock BioNTech (NASDAQ: BNTX) nicely bucked the general downward trend of the market on Monday. The Germany-based biotech’s stock closed more than 5% higher on the day, against the 0.6% rise of the S&P 500 index.

A continued rise in coronavirus cases kept investors interested, but a stronger catalyst was the launch of a stock repurchase program.

So what

That program was announced at the end of March; specifically, BioNTech will buy back up to $1.5 billion worth of its U.S.-listed shares over the next two years. Monday was the start of the initiative.

Image source: Getty Images.

In the original press release heralding the move, BioNTech said it would use the repurchased shares to take care of share-based payment obligations it has committed to.

The biotech quoted its chief financial officer, Jens Holstein, as saying: “We would like our shareholders to participate in our strong 2021 performance through a repurchase program of BioNTech shares. This is in line with our capital allocation strategy and our aim to continue to drive shareholder value.”

As is typical with share buybacks, BioNTech’s current initiative will see the company make its purchases from time to time, and in accordance with market conditions. 

Now what

Meanwhile, the number of coronavirus cases is on the rise in many American cities, not to mention other municipalities and regions around the globe. While this doesn’t necessarily mean that we’re entering a new and frightening phase (the total number of cases is still low relative to the worst months of the pandemic, and fatalities are declining), it is a source of concern.

Should the situation worsen, Comirnaty, the vaccine developed by BioNTech in partnership with Pfizer, will again be a go-to solution for keeping the coronavirus at bay.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US & HK* Trades. Click Here!